Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00872_DB01026_nanopub.RAEpoXljTuocFYMmEhMAxj-CvHDucHSsL5D2HeAOgfdis#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00872_DB01026 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00872_DB01026 label "DDI between Conivaptan and Ketoconazole - Antifungal Agents (Azole Derivatives, Systemic) may decrease the metabolism of Conivaptan. Concomitant use of conivaptan with strong CYP3A4 inhibitors (e.g., azole antifungals) is contraindicated. [drugbank_resource:DB00872_DB01026]" assertion.
- drugbank_resource:DB00872_DB01026 identifier "drugbank_resource:DB00872_DB01026" assertion.
- drugbank_resource:DB00872_DB01026 title "DDI between Conivaptan and Ketoconazole - Antifungal Agents (Azole Derivatives, Systemic) may decrease the metabolism of Conivaptan. Concomitant use of conivaptan with strong CYP3A4 inhibitors (e.g., azole antifungals) is contraindicated." assertion.
- drugbank:DB01026 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00872_DB01026 assertion.
- drugbank:DB00872 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00872_DB01026 assertion.